The Value of Fundamental Biology Research and the Distinction Between Biologics and Small Molecule Drugs

The Value of Fundamental Biology Research and the Distinction Between Biologics and Small Molecule Drugs

In praise of research in fundamental biology, it is evident that Nature has been publishing curiosity-driven research for over 150 years, highlighting its undeniable value. However, we urge policymakers and science-funding agencies to resist the temptation of expecting quick returns from research investments. Fundamental science requires time and patience to unravel the mysteries of life.

One example of the significance of fundamental biology research is the evolution of eukaryotic life, which includes humans. Thijs Ettema and his colleagues embarked on a quest to understand this process. Through their exploration of previously undiscovered microorganisms from the depths of the Atlantic Ocean, they stumbled upon a remarkable discovery. The genomes of these microorganisms contained characteristics of both archaea and eukaryotes, shedding light on our origins as a species. Ettema emphasizes the importance of studying these fascinating organisms in answering the age-old question of where we come from.

While fundamental biology reveals profound insights into life, it is crucial to distinguish between biologics and small molecule drugs. Over the past decade, biologics-based drugs have gained popularity and the number of companies working with biologics continues to rise. In contrast, small molecule drugs undergo drug metabolism primarily through hepatic enzymes, specifically CYPs. These enzymes facilitate the breakdown of small molecules and their subsequent excretion in the urine or feces through conjugative reactions.

Connecting these two seemingly unrelated topics, we can draw attention to the interplay between fundamental biology research and the development of biologics and small molecule drugs. The discoveries made in fundamental biology serve as a foundation for the advancements in drug development. By understanding the intricate workings of cells and organisms, scientists can engineer biologics and small molecule drugs to target specific biological processes. This knowledge allows for more precise and effective treatments for various diseases and conditions.

In conclusion, the value of fundamental biology research cannot be overstated. It provides us with insights into the origins of life and forms the basis for advancements in the development of drugs. Policymakers and science-funding agencies should recognize the importance of investing in long-term fundamental research, as it lays the groundwork for future breakthroughs.

Actionable Advice:

1. Foster a culture of curiosity-driven research: Encourage scientists to pursue fundamental biology research without the pressure of immediate practical applications. This freedom allows for unexpected discoveries and breakthroughs.
2. Promote interdisciplinary collaborations: Encourage scientists from different fields to collaborate and share their expertise. Integrating diverse perspectives can lead to innovative approaches and solutions.
3. Support early-career researchers: Provide funding and resources for young scientists to pursue fundamental biology research. Investing in the next generation of researchers ensures a continuous stream of discoveries and advancements.

In summary, fundamental biology research holds immense value in unraveling the mysteries of life and driving advancements in drug development. By acknowledging its significance and supporting long-term research, we can pave the way for a brighter future in scientific discovery and medical innovation.